2026-09-17
Tru Niagen 300mg keeps first at 9.4 and my ranking holds on its second day. Yesterday I argued that the NR versus NMN choice finally comes down to merit. Today I want to show you the study that tells you how small that merit gap really is, and why it makes brand documentation the deciding factor.
In the first head-to-head human trial of three NAD+ precursors, published in Nature Metabolism by Cuenoud and colleagues at Nestle Health Science, NR and NMN each roughly doubled whole-blood NAD+ after 14 days. Nicotinamide raised it only briefly, around four hours after a dose. The mechanism was the surprise: the data suggest gut bacteria convert NR and NMN into nicotinic acid, a potent NAD+ precursor, and both also raised short-chain fatty acids.
My reading is simple. If the two molecules land in the same place, you should choose the bottle whose contents you can verify. That is why Tru Niagen stays first with its public FDA paperwork, why Thorne NiaCel 400 stays second with NSF certification on the finished product, and why Renue By Science holds fifth as my NMN pick, because its batch numbers match dated certificates.
I want to keep expectations honest too. Ubie's 2026 physician roundup describes human NMN trials at 250 to 500 mg daily over eight to twelve weeks, with modest metabolic and vascular signals and good short-term safety, while lifespan claims remain unproven. That is a reasonable basis for a trial of your own and a thin basis for a long subscription.
My advice: pick NR or NMN on price per verified milligram, take it for twelve weeks, and judge it on how you feel and any bloodwork your doctor already runs.
NR and NMN performed alike
A Nature Metabolism head-to-head found both roughly doubled whole-blood NAD+ after 14 days, while nicotinamide gave only a brief rise.
Gut bacteria do the conversion
The trial suggests microbes turn NR and NMN into nicotinic acid, which then raises NAD+ in blood.
Documentation decides the brand
When the molecules match, verifiable paperwork is the tiebreaker, which keeps Tru Niagen first and Thorne second.
Run a twelve-week test
Human trials ran 8 to 12 weeks at 250 to 500 mg. Use that window to judge value before committing long term.